Navigation Links
Swedish Neuroscience Institute and Institute for Systems Biology in Seattle Form Alliance to Learn More about Brain Diseases
Date:9/30/2008

- Joint fund-raising efforts will support collaborative work of this unique partnership

SEATTLE, Sept. 30 /PRNewswire-USNewswire/ -- The Swedish Neuroscience Institute (SNI) has joined forces with the Institute for Systems Biology (ISB) to fundraise for and collaborate on research they hope will lead to cures for diseases of the brain and nervous system. The new partnership brings together physicians, researchers and fundraisers from two of the most respected organizations in the Pacific Northwest.

Greg Foltz. M.D., SNI neurosurgeon and head of the recently opened Center for Advanced Brain Tumor Treatment at Swedish's Cherry Hill Campus, is jointly leading the project with Leroy Hood, M.D., Ph.D., ISB co-founder and president.

"This is the first time that such a large group of established researchers have been brought together from the fields of neurosurgery, neuropathology, systems biology, genomics and biostatistical analysis to address serious diseases affecting the brain, such as malignant brain tumors," said Dr. Foltz. "Also of significance is the fact that the SNI and ISB researchers are focused solely on developing early diagnostic tools and treatment solutions for human disease rather than theoretical pursuits."

The collaboration also brings to bear some of the most advanced research technologies that exist today.

"The SNI and ISB collaboration represents a powerful strategic partnership that joins the clinical expertise of Swedish with the systems biology, technology and computational expertise of ISB," said Dr. Hood. "This study will integrate many different types of biological information from these patients which may in time lead to a deep understanding of the kinds of brain tumors today that are inevitably fatal."

ISB has been a global leader in the development of systems biology and the effort to identify organ-specific molecular 'fingerprints' in the blood that could lead to the pre-symptomatic diagnosi
'/>"/>

SOURCE Swedish Neuroscience Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
3. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
4. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
5. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
6. Amarin Signs Agreement to Acquire Ester Neurosciences
7. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
8. Rutgers neuroscience may hold key to hearing loss remedy
9. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
10. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
11. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-F... today announced the approval of all of its,"first... District of Delaware,(the "Bankruptcy Court"). de...ef under Chapter 11 of the United States Bankruptc...rders issued by the Bankruptcy Court allow the com...
(Date:11/24/2009)...NGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biola...inistration (SFDA) has approved the,investigationa...project,(Nodlin), an innovative insulin formulatio...axy to initiate its first phase I clinical study. ...f high blood glucose and poor,metabolism. The comp...
(Date:11/24/2009)...y efficacy endpoint has been met for patients with...r, , QUEBEC CITY, Nov. 24 /PRNewswire-FirstCa...AEZ) (the "Company"), a global biopharmaceutical c...today announced positive efficacy data from a Phas...ugate, AEZS-108 (formerly AN-152), in patients wit...
(Date:11/24/2009)...O, Nov. 24, 2009 Arena P...today that the company is scheduled to present at ...ce on December 1, 2009 at 11:30 a.m. Eastern Time ...tel in New York City. Jack Lief, Arena,s President...ide an overview of the company, including its clin...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...CALGARY, Oct. 3 /PRNewswire-FirstCall/ - Dr. Brad ...Inc. (TSX: ONC, NASDAQ: ONCY), will present a,corp...ioPartnering Europe,conference in London, U.K. on ...e held at the Queen Elizabeth II Conference Centre...Inc. Oncolytics is a Calgary-based biotechnology ...
...NEW CANAAN, Conn., Oct. 3 Marshall Edwards,Inc. (...orum 2007 at the San,Francisco Palace Hotel on Thu...ll Edwards, Inc. Marshall Edwards, Inc. (Nasdaq: ...n the clinical development of novel anti-cancer th...gy platform which has generated a,number of novel ...
...,Collaboration, Key to Success, EL SEGUNDO, Calif...eaders" have specific characteristics that positio... fifth annual Global Survey of,Supply Chain Progre...),Supply Chain Management Review and Michigan Stat...y chain professionals in 21 industries,identifies ...
Other Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe 2Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 2Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 32007 Global Survey Identifies Characteristics of Supply Chain Leaders 22007 Global Survey Identifies Characteristics of Supply Chain Leaders 32007 Global Survey Identifies Characteristics of Supply Chain Leaders 4
(Date:11/24/2009)...markable class of ring-shaped protein motors has b...keley National Laboratory (Berkeley Lab) using a s...t the Advanced Light Source (ALS). These protein m...plication, and are vital to the survival of all bi... as the human papillomavirus, which has been linke...
(Date:11/24/2009)...ber 24, 2009) -- The Wildlife Conservation Society... last remaining population of Siberian tigers has ...de of poaching and habitat loss. , W...als of what needs to be done to protect remaining ... The report was released by the Siberian Tig...
(Date:11/24/2009)...a matter of debate. A high-profile study a few yea...f their carbon from trees and leaves, evidence for...atic ecosystems. , But new research from the Uni...be true. Algae provide a much richer diet for fish...lished this week in the Proceedings of the Nation...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Report shows dramatic decline in Siberian tigers 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Siemens Unveils New Hearing Loss Options at SPLASH 3A ADAs 2009 Convention 5863 1Siemens Unveils New Hearing Loss Options at SPLASH 3A ADAs 2009 Convention 5863 2Siemens Unveils New Hearing Loss Options at SPLASH 3A ADAs 2009 Convention 5863 3Siemens Unveils New Hearing Loss Options at SPLASH 3A ADAs 2009 Convention 5863 4Celebrate A New Life Christian Drug Rehab Program Major Expansion in Southern California 60377 1Celebrate A New Life Christian Drug Rehab Program Major Expansion in Southern California 60377 2Celebrate A New Life Christian Drug Rehab Program Major Expansion in Southern California 60377 31 disease not 1 demographic 60373 11 disease not 1 demographic 60373 21 disease not 1 demographic 60373 3
...When invaded by an infectious agent, for example, ...ght and defeat the intruder. But when the biochemi...irected or chronically turned on, inflammation can.... For this reason, scientists are closely studyin...r formation, while others are investigating anti-i...
...nge animal: it feeds by gnawing its way into a car...Scientists at the University of British Columbia (...eeding may cause the stagnant water inside the car...duced by the fish, which could explain why the fis... up to 7% CO2 (350 × that found in normal air). Da...
...e birth to a low-weight preemie at 24 weeks, exhib...ria found in the mouth and the amniotic fluid of a...rinting techniques to find bacteria that cannot be...ase Western Reserve University School of Dental Me...logy at MetroHealth Medical Center in Cleveland ma...
Other Biology News:Inflammation and drugs to control this activity studied in a variety of tumors sites 2Inflammation and drugs to control this activity studied in a variety of tumors sites 3Inflammation and drugs to control this activity studied in a variety of tumors sites 4Inflammation and drugs to control this activity studied in a variety of tumors sites 5Inflammation and drugs to control this activity studied in a variety of tumors sites 6Inflammation and drugs to control this activity studied in a variety of tumors sites 7Inflammation and drugs to control this activity studied in a variety of tumors sites 8Inflammation and drugs to control this activity studied in a variety of tumors sites 9Prenatal nicotine exposure reduces breathing response of newborns... 2Prenatal nicotine exposure reduces breathing response of newborns... 3
Donkey Serum from CHEMICON
Varian Fluorescence Biomelt from Varian, Inc.
... Green reagent (F-2902) was developed in collabora... permit measurement of the kinetics of Fc receptor...tive burst directly in the phagovacuole.2 The Fc O...um albumin (BSA) that has been covalently linked t...
...00+kb), fosmid (40kb), and large plasmid insert (1...he BAC vector. On command 20-50 fold copy amplific...ification. Available with blue-white screening (pE...or the highest insert stability. Kits include elec...
Biology Products: